The study of APOA2 mainly focused on hepatocellular carcinoma, prostate cancer, gastric cancer, myeloma, and pancreatic cancer [26], however, the importance of APOA2 on obstetrics and gynecology was reported recently. This evidence concerns the gene APOA2 and familial pancreatic carcinoma.